694 related articles for article (PubMed ID: 24331309)
1. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
[TBL] [Abstract][Full Text] [Related]
2. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
Osako T; Iwase T; Kimura K; Yamashita K; Horii R; Yanagisawa A; Akiyama F
Cancer; 2011 Oct; 117(19):4365-74. PubMed ID: 21437889
[TBL] [Abstract][Full Text] [Related]
4. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
5. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
[TBL] [Abstract][Full Text] [Related]
6. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
[TBL] [Abstract][Full Text] [Related]
7. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
[TBL] [Abstract][Full Text] [Related]
8. Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer.
Khaddage A; Berremila SA; Forest F; Clemenson A; Bouteille C; Seffert P; Peoc'h M
Anticancer Res; 2011 Feb; 31(2):585-90. PubMed ID: 21378342
[TBL] [Abstract][Full Text] [Related]
9. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
[TBL] [Abstract][Full Text] [Related]
11. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
Godey F; Leveque J; Tas P; Gandon G; Poree P; Mesbah H; Lavoue V; Quillien V; Athias CB
Breast Cancer Res Treat; 2012 Jan; 131(2):509-16. PubMed ID: 21993859
[TBL] [Abstract][Full Text] [Related]
13. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
[TBL] [Abstract][Full Text] [Related]
14. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
15. [One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: A cost-benefit analysis].
Guillén-Paredes MP; Carrasco-González L; Cháves-Benito A; Campillo-Soto A; Carrillo A; Aguayo-Albasini JL
Cir Esp; 2011; 89(7):456-62. PubMed ID: 21664607
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
17. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.
Geertsema D; Gobardhan PD; Madsen EV; Albregts M; van Gorp J; de Hooge P; van Dalen T
Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461
[TBL] [Abstract][Full Text] [Related]
18. Validation of a technique using microbubbles and contrast enhanced ultrasound (CEUS) to biopsy sentinel lymph nodes (SLN) in pre-operative breast cancer patients with a normal grey-scale axillary ultrasound.
Cox K; Sever A; Jones S; Weeks J; Mills P; Devalia H; Fish D; Jones P
Eur J Surg Oncol; 2013 Jul; 39(7):760-5. PubMed ID: 23632319
[TBL] [Abstract][Full Text] [Related]
19. Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.
Di Filippo F; Di Filippo S; Ferrari AM; Antonetti R; Battaglia A; Becherini F; Bernet L; Boldorini R; Bouteille C; Buglioni S; Burelli P; Cano R; Canzonieri V; Chiodera P; Cirilli A; Coppola L; Drago S; Di Tommaso L; Fenaroli P; Franchini R; Gianatti A; Giannarelli D; Giardina C; Godey F; Grassi MM; Grassi GB; Laws S; Massarut S; Naccarato G; Natalicchio MI; Orefice S; Palmieri F; Perin T; Roncella M; Roncalli MG; Rulli A; Sidoni A; Tinterri C; Truglia MC; Sperduti I
J Exp Clin Cancer Res; 2016 Dec; 35(1):193. PubMed ID: 27931238
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
